Oncology CT

Research data reveals using LDCT with patients who have never smoked – but who are still at high risk – is effective for lung cancer screening.

Here's what to expect this week on Diagnostic Imaging.

Perivascular Spaces & Dementia; COVID-19 Loss of Smell and Taste; NAFLD & Multi-parametric CT; Plus, Point-of-Care Ultrasound in the Pandemic Era

Whole-body MRI was able to detect more lesions and identify more patients for earlier treatment.

COVID-19 Vaccine Adenopathies Mimic Breast Malignancies; Appendicitis, CT Exposure and Increased Cancer Risk; and MRI AI Tool for Prostate Cancer Recurrence Prediction

Aquilion system offers industry’s largest bore and widest field-of-view, potentially augmenting radiation therapy planning.

The number of CT scans corresponds to an increase in risk of hematologic malignant neoplasms, especially in children under age 16.

An early analysis shows that low-dose CT screening for lung cancer has still not fully rebounded, leading to later detection of cancers.

Low-dose CT screening for lung cancer does present risks of false-positives and over-diagnosis, but for heavy or ex-smokers, it is worth it.

DECT and electron density offers more accurate differentiation between metastatic and non-metastatic lymph nodes when compared to FDG PET/CT.

Low-dose CT for lung cancer screening offers significant benefits for detection and follow-up, but utilization, to date, has been low. Debra S. Dyer, M.D., chair of the American College of Radiology's Lung Cancer Screening 2.0 Committee discusses what the screening provides and the challenges to more widespread implementation.

Here's what to expect this week on Diagnostic Imaging.

Third annual report from the American Lung Association reveals 94 percent of high-risk eligible patients are not getting screening with LDCT, and access and outcomes are worse for racial and ethnic minorities.

Rapid COVID-19 Diagnosis with CT and CO-RADS; Cooled Radiofrequency Ablation for Pain Relief; Inappropriate Abdominal CT and Ultrasound Scans; and Lead Shielding Guidance

States with higher lung cancer burden have lower low-dose CT lung cancer screening rates.

Diagnostic Imaging and Testicular Cancer Risk; Digital Breast Tomosynthesis/Synthetic Mammography Combination for Breast Cancer Screening; Efficacy of Low-Dose CT Lung Cancer Screening; and the Evolving Role of the Radiologic Technologist

Even potential for over-diagnosis does not appear to increase other causes of mortality.

Cerebral Aneurysms and CT Angiography; MammoScreen and Breast Cancer Detection; Low-Dose Lung Cancer Screening Program Performance; and Breast Cancer Screening Advocacy Efforts

In a study from China, there was no statistical significance in cancer detection rates between high-risk patients who were screened and those who were not.

In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.

Here's what to expect this week on Diagnostic Imaging.

Breast Cancer Screening in Indian & Pakistani Women; Fluciclovine PET for Prostate Cancer Imaging; Cardiac Ultrasound & COVID-19; and Improving Mammography Patient Experience

Research indicates patients who undergo a single 28-Gy session experience similar outcomes to those who have four 12-Gy sessions, pointing to safer, faster treatment.

18F-fluciclovine PET/MRI can improve treatment guidance with better staging and evaluation of androgen deprivation therapy.

African American, as well as other racial and ethnic minority, patients likely have lower levels of CTC screening due to out-of-pocket costs.